Evidence map›Paper›PMID 38324301›Full record

ReviewInvestigative ophthalmology & visual science2024

Role of Serine Protease Inhibitors A1 and A3 in Ocular Pathologies.

Richard Kontoh-Twumasi, Stepan Budkin, Neel Edupuganti, Ayushi Vashishtha, Shruti Sharma

Open access · goldAbstract readReview
In one paragraph

Review in Investigative ophthalmology & visual science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Richard Kontoh-TwumasiCenter for Biotechnology and Genomic Medicine, Augusta University, Augusta, Georgia, United States.
Stepan BudkinCenter for Biotechnology and Genomic Medicine, Augusta University, Augusta, Georgia, United States.
Neel EdupugantiCenter for Biotechnology and Genomic Medicine, Augusta University, Augusta, Georgia, United States.
Ayushi VashishthaMorsani College of Medicine, University of South Florida, Tampa, Florida, United States.
Shruti SharmaCenter for Biotechnology and Genomic Medicine, Augusta University, Augusta, Georgia, United States.
Augusta University Health · USAugusta University · USUniversity of South Florida · US

Funding

Module 3: Gene Expression/ProteomicsP30EY031631 · NEI · AUGUSTA UNIVERSITY · PI Xingjun Fan · 2020 to 2026
$3.6M
Targeting Interleukin-6 Trans-signaling in Diabetic RetinopathyR01EY026936 · NEI · AUGUSTA UNIVERSITY · PI SHARMA, SHRUTI · 2016 to 2019
$1.5M
NEI NIH HHS P30 EY031631NEI NIH HHS R01 EY026936
6 · The paper itself

Abstract

Serine protease inhibitors A1 (SerpinA1) and A3 (SerpinA3) are important members of the serpin family, playing crucial roles in the regulation of serine proteases and influencing various physiological processes. SerpinA1, also known as α-1-antitrypsin, is a versatile glycoprotein predominantly synthesized in the liver, with additional production in inflammatory and epithelial cell types. It exhibits multifaceted functions, including immune modulation, complement activation regulation, and inhibition of endothelial cell apoptosis. SerpinA3, also known as α-1-antichymotrypsin, is expressed both extracellularly and intracellularly in various tissues, particularly in the retina, kidney, liver, and pancreas. It exerts anti-inflammatory, anti-angiogenic, antioxidant, and antifibrotic activities. Both SerpinA1 and SerpinA3 have been implicated in conditions such as keratitis, diabetic retinopathy, age-related macular degeneration, glaucoma, cataracts, dry eye disease, keratoconus, uveitis, and pterygium. Their role in influencing metalloproteinases and cytokines, as well as endothelial permeability, and their protective effects on Müller cells against oxidative stress further highlight their diverse and critical roles in ocular pathologies. This review provides a comprehensive overview of the etiology and functions of SerpinA1 and SerpinA3 in ocular diseases, emphasizing their multifaceted roles and the complexity of their interactions within the ocular microenvironment.

Indexed as

Eye DiseasesSerpinsalpha 1-AntitrypsinAntioxidantsApoptosisEyeHumansLiveralpha 1-AntitrypsinAntioxidantsSERPINA1 protein, humanSERPINA3 protein, humanSerpins

Identifiers

PMID38324301
PMCPMC10854419
OpenAlexW4391598018

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.